Glibornuride

Summary

Glibornuride (CHEMBL529888) is an approved small molecule (ATC A10BB04); indicated across 1 condition including diabetes mellitus.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• ATC class: A10BB04
• Indications: 1 condition
• Chemistry: 366.5 Da · C18H26N2O4S

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL529888
Name	Glibornuride
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	12818200
ATC	A10BB04
Molecular formula	C18H26N2O4S
Molecular weight	366.5
InChIKey	RMTYNAPTNBJHQI-LLDVTBCESA-N

SMILES: CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N[C@H]2[C@H]3CC[C@@]([C@H]2O)(C3(C)C)C

IUPAC name: 1-[(1S,2S,3R,4R)-3-hydroxy-4,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]-3-(4-methylphenyl)sulfonylurea

Also known as: Glibornurida, Glibornuride, Glutril, RO-64563, GLIBORNURIDE, glibornuride

Patent coverage: 1,127 distinct patent families (3,837 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

1 indication (1 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

Indication	Trial phase	MONDO	EFO
diabetes mellitus	4	MONDO:0005015	EFO:0000400

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).